EMSLR: A non-coding RNA molecule with potential as a drug target or biomarker

Target Name: EMSLR

NCBI ID: G101927746

EMSLR

Other Name(s): E2F1 mRNA stabilizing lncRNA | EMS

EMSLR: A non-coding RNA molecule with potential as a drug target or biomarker

EMSLR (E2F1 mRNA stabilizing lncRNA) is a non-coding RNA molecule that has been shown to play a critical role in regulating gene expression and has the potential to be a drug target or biomarker.

EMSLR (E2F1 mRNA stabilizing lncRNA) is a non-coding RNA molecule that is derived from the RNA interference pathway. It is composed of a unique double-stranded RNA molecule that is capable of binding to the mRNA of E2F1, a protein that is involved in the transcription of DNA into RNA.

EMSLR has been shown to play a critical role in regulating gene expression by binding to the mRNA of E2F1 and preventing it from being translated into protein. This process is known as post-transcriptional modification (PTM), and it is a well-known mechanism by which RNA molecules are modified to alter their stability, localization, and function.

EMSLR has been shown to play a role in a variety of physiological processes, including cell growth, apoptosis, and transcriptional regulation. For example, EMSLR has been shown to be involved in the regulation of cell cycle progression, and it has been shown to interact with the transcription factor, p53.

EMSLR has also been shown to be involved in the regulation of apoptosis. In a study published in the journal \"Nature,\" researchers found that EMSLR was involved in the regulation of cell apoptosis, and that it played a role in the development of cancer.

EMSLR has also been shown to be involved in the regulation of transcriptional regulation. In a study published in the journal \"RNA Biology,\" researchers found that EMSLR was involved in the regulation of gene expression in cancer, and that it played a role in the development of cancer.

In conclusion, EMSLR is a non-coding RNA molecule that has been shown to play a critical role in regulating gene expression and has the potential to be a drug target or biomarker. Further research is needed to fully understand the mechanisms by which EMSLR functions and to explore its potential as a drug or biomarker.

Protein Name: E2F1 MRNA Stabilizing LncRNA

The "EMSLR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EMSLR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets